AstraZeneca Q3 profit beats estimates as cancer drug sales drive growth
Read original article on Breaking News on Seeking Alpha →Related news
-
OFS Capital declares $0.17 dividend
Economy
Markets
-
North European Oil Royalty Trust announces variable dividend of $0.20
Economy
Markets
-
Spotify said to target launching AI music remix service in 2027
Technology
AI
-
Crypto markets slide as Binance probes $6.3B security breach, aims to resume withdrawals in 48 hours
Technology
Cybersecurity
-
AstraZeneca PLC Non-GAAP EPS of $2.79, revenue of $16.21B beats by $210M; reaffirms FY2026 outlook
Business
Corporate
- Coursera expects $358M-$366M Q4 revenue as integration targets >$150M gross cost savings by year-end Technology Web
- Euro markets slip as tech selloff weighs on sentiment Economy Markets Europe
- Shoppers’ stocks shine on earnings day while tech takes the hit Economy Markets Global